Pathoanatomy of Parkinson's disease

Journal of Neurology, Supplement

Volumn 247, Issue 2, 2000, Pages 3-10

  Braak, Heiko ^a   Braak, Eva ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

synuclein; Cytoskeletal alterations; Limbic system; Motor system; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

AMYGDALOID NUCLEUS; BRAIN CORTEX; CELL INCLUSION; CELL NUCLEUS; CONFERENCE PAPER; HUMAN; HYPOTHALAMUS; LEWY BODY; LIMBIC SYSTEM; MOTOR SYSTEM; NEURITE; NEUROPATHOLOGY; PARKINSON DISEASE; PERIKARYON; PRIORITY JOURNAL; STRIA TERMINALIS; SUBSTANTIA NIGRA;

BRAIN; HUMANS; NEURAL PATHWAYS; PARKINSON DISEASE;

EID: 0034007822     PISSN: 09391517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Alexander GE, Crutcher MD, DeLong MR (1990) Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res 85:119-146
2. Alheid GF, Heimer L, Switzer RC (1990) Basal ganglia. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 483-582
3. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VMY, Trojanowski JQ, Iwatsubo T (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884
4. Bancher C, Lassmann H, Budka H, Jellinger K, Grundke-Iqbal K, Wiche G, Seitelburger F, Wisniewski HM (1989) An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 48:81-93
5. Bergeron C, Pollanen MS (1996) Pathogenesis of the Lewy body. In: Perry R, McKeith I, Perry E (eds) Dementia with Lewy bodies. Cambridge University Press, New York, pp 302-308
6. Braak E, Braak H (1999) Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy. J Neurosci Methods 87:111-115
7. Braak H (1980) Architectonics of the human telencephalic cortex. In: Braitenberg V, Barlow HB, Bizzi E, Florey E, Grüsser OJ, van der Loos H (eds) Studies of brain function. Springer, Berlin, pp 1-147
8. Braak H, Braak E (1986) Nuclear configuration and neuronal types of the nucleus niger in the human adult. Hum Neurobiol 5:71-82
9. Braak H, Braak E (1993) Anatomy of the human basal ganglia. In: Szelenyi I led) Inhibitors of monoamine oxidase B. Birkhäuser, Basel, pp 3-23
10. Braak H, Braak E, Yilmazer D, De Vos RAI, Jansen ENH, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88: 493-500
11. Braak H, Braak E, Yilmazer D, Schultz C, De Vos RAI, Jansen ENH (1995) Nigral and extranigral pathology in Parkinson's disease. J Neural Transm 46:15-31
12. Braak H, De Vos RAI, Jansen ENH, Bratzke H, Braak E (1998) Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog Brain Res 117:267-285
13. Braak H, Sandmann-Keil D, Gai WP, Braak E (1999) Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by α-synuclein. Neurosci Lett 265: 67-69
14. Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol 287: 373-392
15. de Vos RAI, Jansen ENH, Yilmazer D, Braak H, Braak E (1996) Pathological and clinical features of Parkinson's disease with and without dementia. In: Perry R, McKeith I, Perry E (eds) Dementia with Lewy bodies. Cambridge University Press, New York, pp 238-248
16. Den Hartog Jager WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomie nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23: 283-290
17. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen SH (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 41: 1402-1409
18. Dickson DW, Schmidt ML, Lee VMY, Zhuo ML, Yen Sh, Trojanowski JQ (1994) Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 87:269-276
19. Eadie MJ (1963) The pathology of certain medullary nuclei in Parkinsonism. Brain 86:781-795
20. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301
21. Fearnley JM, Lees AJ (1994) Pathology of Parkinson's disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 545-554
22. Foley P, Riederer P (1999) Pathogenesis and preclinical course of Parkinson's disease. J Neural Transm Suppl 56:31-74
23. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272
24. Gai WP, Blumbergs PC, Blessing WW (1996) Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease. Acta Neuropathol 91: 78-81
25. Gai WP, Geffen LB, Denoroy L, Blessing WW (1993) Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson's disease. Ann Neurol 33:357-367
26. Gibb WRG (1991) Neuropathology of the substantia nigra. Eur Neurol 31:48-59
27. Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
28. Gibb WRG, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 15:27-44
29. Gibb WRG, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54:388-396
30. Goedert M (1997) The awakening of α-synuclein. Nature 388:232-233
31. Goto S, Hirano A (1991) Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease. Ann Neurol 30:192-196
32. Graybiel AM, Hirsch EC, Agid Y (1990) The nigrostriatal system in Parkinson's disease. Adv Neurol 53: 17-29
33. Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, Dasilva J, Houle S (1997) [C-11]RTI-32-PET studies of the dopamine transporter in early dopanaïve Parkinson's disease - implications for the symptomatic threshold. Neurology 48:1578-1583
34. Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RGH, Howe PRC, Blessing WW, Geffen LB (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27:373-385
35. Hassler R (1938) Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 48:387-176
36. Heimer L, De Olmos J, Alheid GF, Zaborszky L (1991) "Perestroika" in the basal forebrain: opening the border between neurology and psychiatry. Prog Brain Res 87:109-165
37. Hirsch EC, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334:345-347
38. Holstege G (1992) The emotional motor system. Eur J Morphol 30:67-79
39. Holstege G (1996) The somatic motor system. Prog Brain Res 107:9-26
40. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases [see comments]. J Neurol Neurosurg Psychiatry 55:181-184
41. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neuntes in Parkinson's disease and cortical Lewy bodies disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334-337
42. Iwatsubo T, Yamaguchi H, Fujimoro M, Yokosawa H, Ihara Y, Trojanowski JQ, Lee VM (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 148: 1517-1529
43. Jellinger K (1987) The pathology of parkinsonism. In: Marsden CD, Fahn S (eds) Movement disorders, vol. 2. Butterworths, London, pp 124-165
44. Jellinger K (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14: 153-197
45. Koller WC (1992) How accurately can Parkinson's disease be diagnosed? Neurology 42:6-16
46. Langston JW, Forno LS (1978) The hypothalamus in Parkinson disease. Ann Neurol 3:129-133
47. Leigh PN, Probst A, Dale GE, Power DP, Brion JP, Dodson A, Anderton BH (1989) New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol 79:61-72
48. Lennox GG, Lowe JS (1998) Dementia with Lewy bodies. In: Markesbery WJ (ed) Neuropathology of dementing disorders, Arnold, London, New York, Sydney, Auckland, pp 181-192
49. Lewy FH (1912) Paralysis agitans. I. Pathologische Anatomie. In: Lewandowski M (ed) Handbuch der Neurologie. Springer, Berlin, pp 920-933
50. Lewy FH (1923) Die Lehre vom Tonus und der Bewegung, zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Palhogenese der Paralysis agitans. Springer, Berlin
51. Lowe J (1994) Lewy bodies. In: Calne DP (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 51-69
52. Malessa S, Hirsch EC, Cervera P, Duyckaerts C, Agid Y (1990) Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes; a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striationigral degeneration. Neurology 40:1739-1743
53. Mann DMA, Yates PO (1983) Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathol Appl Neurobiol 9:3-19
54. Matzuk MM, Saper CB (1985) Preservation of hypothalamic dopaminergic neurons in Parkinson's disease. Ann Neurol 18:552-555
55. Mesulam MM (1998) From sensation to cognition. Brain 121:1013-1052
56. Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [F-18] dopa PET. J Neurol Neurosurg Psychiatry 64: 314-319
57. Nauta WJH (1986) Circuitous connections linking cerebral cortex, limbic system, and corpus striatum. In: Doane BK, Livingstone KE (eds) The limbic system. Raven Press, New York, pp 43-54
58. Nieuwenhuys R (1996) The greater limbic system, the emotional motor system and the brain. Prog Brain Res 107:551-580
59. Oades RD, Halliday GM (1987) Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res Rev 12:117-165
60. Ohama E, Ikuta F (1976) Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol 34:311-319
61. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183-191
62. Sandmann-Keil D, Braak H, Okochi M, Haass C, Braak E (1999) Alpha-synuclein immunoreactive Lewy bodies and Lewy neuntes in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol (in press)
63. Saper CB, Sorrentino DM, German DC, de Lacalle S (1991) Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease. Ann Neurol 29:577-584
64. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469-6473
65. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M (1997) α-synuclein in Lewy bodies. Nature 388:839-840
66. Trojanowski JQ, Lee VMY (1998) Aggregation of neurofilament and α-synuclein proteins in Lewy bodies - implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch Neurol 55:151-152
67. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 239: 45-48
68. Zilles K (1990) Cortex. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 757-802